뒤로
Bright Minds Biosciences Inc(DRUG) 가격
DRUG 주가 차트
DRUG 수입
Bright Minds Biosciences Inc
$88
-2.12%
$-1.9
종가: Jan 16, 16:00:00 GMT-5
$89.74
1.97%
$1.73
애프터마켓: Jan 16, 20:00:00 GMT-5
주요 통계
이전 종가
$89.91
시가
$89.59
일일 범위
$86.39 - $89.74
52주 범위
$23.17 - $123.75
거래량
111.4K
평균 거래량
209.4K
EPS(TTM)
-1.30
배당수익률
--
시가총액
$698.8M
DRUG란 무엇인가요?
Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company is headquartered in New York City, New York and currently employs 0 full-time employees. The company went IPO on 2021-02-08. The firm is focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders. Its Serotonin (5-HT) is a neurotransmitter in the brain and modulates many biological functions. Dysfunction of serotonin receptors, transporters, and associated neurocircuits is fundamental to many diseases including epilepsies and neuro psychiatric. Its pipeline includes BMB-101, BMB-xxx, BMB-201, and BMB-202. The firm has a portfolio of patented, selective serotonin (5-HT2C, 5-HT2A and 5-HT2C/A-receptor subtypes) agonists that were identified by using high-throughput screening methods in combination with advanced molecular modeling techniques to interrogate the interaction between the drug and its targeted receptors to increase downstream signaling.